{"nctId":"NCT00276458","briefTitle":"To Evaluate Ezetimibe Plus Atorvastatin Versus Atorvastatin in Patients With High Cholesterol Not Controlled on Atorvastatin 20 mg (0653-079)(COMPLETED)","startDateStruct":{"date":"2006-02"},"conditions":["Hypercholesterolemia"],"count":196,"armGroups":[{"label":"1","type":"ACTIVE_COMPARATOR","interventionNames":["Drug: Comparator: atorvastatin","Drug: Comparator: Placebo"]},{"label":"2","type":"EXPERIMENTAL","interventionNames":["Drug: Comparator: ezetimibe","Drug: Comparator: Placebo."]}],"interventions":[{"name":"Comparator: atorvastatin","otherNames":[]},{"name":"Comparator: Placebo","otherNames":[]},{"name":"Comparator: ezetimibe","otherNames":[]},{"name":"Comparator: Placebo.","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Patient with LDL-C \\>100 mg/dL \\& on a stable dose of atorvastatin 20 mg\n\nExclusion Criteria:\n\n* Pregnant or lactating women or intending to become pregnant\n* Patient with sensitivity or intolerance to ezetimibe or atorvastatin\n* Patient with diabetes or coronary heart disease","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","maximumAge":"79 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Percent Change From Baseline in Low Density Lipoprotein-Cholesterol (LDL-C) at Week 6","description":"\\[(6 week value - baseline value)/baseline value\\]\\*100%.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-30.8","spread":null},{"groupId":"OG001","value":"-10.9","spread":null}]}]}]},{"type":"SECONDARY","title":"Percent Change in High Density Lipoprotein -Cholesterol (HDL-C)at Week 6","description":"\\[(6 week value - baseline value)/baseline value\\]\\*100%.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"3.2","spread":null},{"groupId":"OG001","value":"0.8","spread":null}]}]}]},{"type":"SECONDARY","title":"Percent Change in Non-High Density Lipoprotein Cholesterol (Non-HDL-C) at Week 6","description":"\\[(6 week value - baseline value)/baseline value\\]\\*100%.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-26.7","spread":null},{"groupId":"OG001","value":"-10.2","spread":null}]}]}]},{"type":"SECONDARY","title":"Percent Change From Baseline in Total-Cholesterol at Week 6","description":"(\\[6 week value - baseline value)/baseline value\\]\\*100%.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-19.7","spread":null},{"groupId":"OG001","value":"-7.4","spread":null}]}]}]},{"type":"SECONDARY","title":"Percent Change From Baseline in Triglycerides (TG) at Week 6","description":"\\[(6 week value - baseline value)/baseline value\\]\\*100%.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-17.8","spread":null},{"groupId":"OG001","value":"-5.5","spread":null}]}]}]},{"type":"SECONDARY","title":"Percent Change From Baseline in Apolipoprotein B at Week 6","description":"\\[(6 week value - baseline value)/baseline value\\]\\*100%.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-21.4","spread":null},{"groupId":"OG001","value":"-7.7","spread":null}]}]}]},{"type":"POST_HOC","title":"Percent Change in Apolipoprotein A-I at Week 6","description":"\\[(6 week value - baseline value)/baseline value\\]\\*100%.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-1.9","spread":null},{"groupId":"OG001","value":"-1.2","spread":null}]}]}]},{"type":"SECONDARY","title":"Percent Change From Baseline in Total-Cholesterol:High Density Lipoprotein Cholesterol (HDL-C) Ratio at Week 6","description":"\\[(6 week value - baseline value)/baseline value\\]\\*100%.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-20.6","spread":null},{"groupId":"OG001","value":"-7.5","spread":null}]}]}]},{"type":"SECONDARY","title":"Percent Change From Baseline in Low Density Lipoprotein Cholesterol (LDL-C):High Density Lipoprotein Cholesterol (HDL-C) Ratio at Week 6","description":"\\[(6 week value - baseline value)/baseline value\\]\\*100%.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-31.9","spread":null},{"groupId":"OG001","value":"-11.0","spread":null}]}]}]},{"type":"SECONDARY","title":"Percent Change From Baseline in Apolipoprotein B: Apolipoprotein A-I Ratio at Week 6","description":"\\[(6 week value - baseline value)/baseline value\\]\\*100%.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-19.0","spread":null},{"groupId":"OG001","value":"-5.8","spread":null}]}]}]},{"type":"SECONDARY","title":"Percent Change From Baseline in Non-High Density Lipoprotein Cholesterol (HDL-C):High Density Lipoprotein Cholesterol (HDL-C) Ratio at Week 6","description":"\\[(6 week value - baseline value)/baseline value\\]\\*100%.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-27.2","spread":null},{"groupId":"OG001","value":"-9.9","spread":null}]}]}]},{"type":"SECONDARY","title":"Percent Change From Baseline in C-Reactive Protein (CRP) at Week 6","description":"\\[(6 week value - baseline value)/baseline value\\]\\*100%.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-6.7","spread":null},{"groupId":"OG001","value":"-9.2","spread":null}]}]}]},{"type":"POST_HOC","title":"Percent Change in C-Reactive Protein (CRP) at Week 6","description":"\\[(6 week value - baseline value)/baseline value\\]\\*100%.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-19.2","spread":null},{"groupId":"OG001","value":"-9.1","spread":null}]}]}]},{"type":"SECONDARY","title":"Number of Participants Who Attained Target LDL-C <100 mg/dL at Week 6","description":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"77","spread":null},{"groupId":"OG001","value":"45","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"15","spread":null},{"groupId":"OG001","value":"47","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":0,"n":96},"commonTop":["Fatigue","Vertigo","Irritable bowel syndrome","Gastroenteritis","Nasopharyngitis"]}}}